Assessment of Urinary Methylmalonic Acid Levels in Older Adults on Proton Pump Inhibitors
Background: Proton pump inhibitors (PPIs) affect gastric acid secretion. The use of PPIs in the elderly population (> 70 years old) may increase the risk of vitamin B12 deficiency because gastric acid is needed for vitamin B12 digestion and absorption. However, it’s unclear whether adults aged 50-70 years old that use PPIs chronically are at risk of vitamin B12 deficiency. Aim: To determine whether chronic use of proton pump inhibitors results in increased urinary methylmalonic acid (uMMA) levels in adults aged 50-70 years old, indicating vitamin B12 deficiency. Method: Fifteen men and women who had been taking proton pump inhibitors daily for a minimum of one year were recruited. Fifteen subjects, not taking proton pump inhibitors, were age-matched (± 3 years) and gender matched, to the subjects taking proton pump inhibitors. Tissue stores of vitamin B12 were determined using uMMA. Results: There were no significant differences in uMMA levels between those taking proton pump inhibitors (Mdn = 1.60 µg uMMA/ mg creatinine), and those not taking proton pump inhibitors (Mdn = 1.80 µg uMMA/mg creatinine) (p = 0.12). Conclusion: Chronic use of proton pump inhibitors did not affect vitamin B12 status of subjects in this pilot study of healthy adults aged 50-70 years old. Regular monitoring of vitamin B12 status does not appear to be needed in this age group, however, studies using larger groups are indicated to confirm these findings.
